Anais Bleuzen

Assistant Engineer

anais.bleuzen {at} inserm.fr

Being passionate about biotherapies, I have been involved in a gene therapy project for Duchenne muscular dystrophy, using the Crispr/Cas9 technology to restore or partially restore dystrophin.